CN104187674A - 含有银杏叶提取物的海狗油软胶囊 - Google Patents
含有银杏叶提取物的海狗油软胶囊 Download PDFInfo
- Publication number
- CN104187674A CN104187674A CN201410451356.7A CN201410451356A CN104187674A CN 104187674 A CN104187674 A CN 104187674A CN 201410451356 A CN201410451356 A CN 201410451356A CN 104187674 A CN104187674 A CN 104187674A
- Authority
- CN
- China
- Prior art keywords
- seal oil
- soft capsule
- ginkgo biloba
- oil soft
- biloba extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 14
- 239000009429 Ginkgo biloba extract Substances 0.000 title abstract 3
- 229940068052 ginkgo biloba extract Drugs 0.000 title abstract 3
- 235000020686 ginkgo biloba extract Nutrition 0.000 title abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 10
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000010445 lecithin Nutrition 0.000 claims abstract description 6
- 239000000787 lecithin Substances 0.000 claims abstract description 6
- 229940067606 lecithin Drugs 0.000 claims abstract description 6
- 229940031439 squalene Drugs 0.000 claims abstract description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 11
- 244000194101 Ginkgo biloba Species 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 235000019197 fats Nutrition 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 206010002482 Angiosclerosis Diseases 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010011084 Coronary artery embolism Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种含有银杏叶提取物的海狗油软胶囊，主要有效成分是：海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]、银杏叶提取物和卵磷脂，主要辅料为水、维生素E、甘油和食用动物明胶。本发明的有益效果是： 不仅可以有效地降低血液中的胆固醇和脂肪含量、降低血液黏度，软化和扩张血管，预防动脉血管硬化、血栓等疾病的发生，而且还有营养大脑、改善记忆、预防高血压病发生的功效。
Description
（一）技术领域
本发明涉及一种海狗油软胶囊，尤其是一种含有银杏叶提取物的海狗油软胶囊，属于保健食品技术领域。
（二）背景技术
目前，随着生活水平的不断提高，人们对高脂肪肉类食品的摄入量不断增加，伴随而来的是血液中胆固醇和脂肪含量的不断升高，由此引起的心、脑动脉血管硬化、血栓、冠心病和高血压等疾病日益影响和危害着中老年人的健康。为了预防和减少此类疾病的发生，人们开始食用一些海狗油类保健食品，用以降低血液中的胆固醇和脂肪含量。由于市场上现有的各种海狗油类保健食品普遍存在功效成分简单、功效成含量比例不合理的缺点，产品的功能单一、效果不明显，很难起到理想的预防疾病和保健作用。
（三）发明内容
本发明为了弥补现有技术的不足，提供了一种含有银杏叶提取物的海狗油软胶囊，主要有效成分是：海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]、卵磷脂、银杏叶提取物，主要辅料为水、维生素E、甘油和食用动物明胶。
海狗油中EPA：俗称“血管清道夫”， 可以降低血脂及胆固醇含量，抑制血小板凝聚，具有防止血管硬化、心脑血管栓塞，降低高血压的作用。可以预防冠状动脉硬化和栓塞，脑中风、脑溢血、脑血管障碍，高胆固醇、高血脂、高血压，手脚麻痹，心悸等各种心脑血管疾病。DHA：俗称“脑黄金”，是脑组织和视神经发育及功能发挥所必须的营养物质。可用于增强记忆力，促进婴幼儿智力开发及提高智商，预防和治疗老年痴呆症。DPA：可提高人体的免疫力，对糖尿病、类风湿性关节炎、牛皮癣、气喘病，溃疡性大小肠炎等均有治疗作用。角鲨烯：天然抗氧化剂，有助于防癌和抗癌，并能滋润皮肤使其光滑而富弹性。
银杏叶提取物具有抗炎、抗过敏、扩张血管、改善外周血液循环，降低血清胆固醇及辅助抗癌的作用，广泛用于心脑血管疾病的预防和保健作用。卵磷脂具有营养大脑预防软化血管和减缓记忆力衰退的功效。
维生素E能够保护高度不饱和脂肪酸（EPA、DHA、DPA）不被氧化，延长产品保质期。
本发明的有益效果是，该海狗油软胶囊不仅可以有效地降低血液中的胆固醇和脂肪含量、降低血液黏度，软化和扩张血管，预防动脉血管硬化、血栓等疾病的发生，而且还有营养大脑、改善记忆、预防高血压病发生的功效。
（四）具体实施方式
1、配制内容物：将原材料海狗油、银杏叶提取物油、维生素E按照一定的配方混合到一起，搅拌均匀，胶囊内容物功效成分净含量的质量百分比为10～15%的EPA、20～25% 的DHA、10～15% 的DPA、4～8%的角鲨烯、5～6%的卵磷脂、 2～3%的银杏叶提取物和1%的维生素E，其余为海狗油中的其它非功效成分。
2、制作胶囊体材料：以食用明胶、甘油和纯净水为囊体原料，将甘油和纯净水按照比例注入溶胶罐内，加热搅拌至75℃左右，再加入明胶，继续搅拌20～30分钟后真空脱泡，制作得到囊体材料。
3、将配好的内容物和胶囊体经过压丸、成型、洗丸、干燥，制成成品海狗油软胶囊。
Claims (2)
1.含有银杏叶提取物的海狗油软胶囊，其特征在于：胶囊内容物原料的质量百分比为海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）、角鲨烯]：90～92% 、银杏叶提取物：2～3% 、卵磷脂5～6%、维生素E：1% 。
2.根据权利要求1所述含有银杏叶提取物的海狗油软胶囊，其特征在于：胶囊内容物功效成分的质量百分比为：EPA：10～15%、DHA：20～25%、DPA：10～15%、角鲨烯4～8%，银杏叶提取物：2～3%、卵磷脂5～6%，其余为1%的维生素E（抗氧化剂）和海狗油中的其它非功效成分。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451356.7A CN104187674A (zh) | 2014-09-07 | 2014-09-07 | 含有银杏叶提取物的海狗油软胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410451356.7A CN104187674A (zh) | 2014-09-07 | 2014-09-07 | 含有银杏叶提取物的海狗油软胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104187674A true CN104187674A (zh) | 2014-12-10 |
Family
ID=52073189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410451356.7A Pending CN104187674A (zh) | 2014-09-07 | 2014-09-07 | 含有银杏叶提取物的海狗油软胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104187674A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0731417A (ja) * | 1993-07-20 | 1995-02-03 | Health Eido:Kk | カプセル栄養補助食品 |
| CN1518989A (zh) * | 2003-01-21 | 2004-08-11 | 刘 威 | 海狗油软胶囊及其在制备调节血脂保健品中的应用 |
| CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
| CN103989179A (zh) * | 2014-05-07 | 2014-08-20 | 宁波市成大机械研究所 | 含有银杏叶提取物的深海鱼油软胶囊 |
-
2014
- 2014-09-07 CN CN201410451356.7A patent/CN104187674A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0731417A (ja) * | 1993-07-20 | 1995-02-03 | Health Eido:Kk | カプセル栄養補助食品 |
| CN1518989A (zh) * | 2003-01-21 | 2004-08-11 | 刘 威 | 海狗油软胶囊及其在制备调节血脂保健品中的应用 |
| CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
| CN103989179A (zh) * | 2014-05-07 | 2014-08-20 | 宁波市成大机械研究所 | 含有银杏叶提取物的深海鱼油软胶囊 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652867B (zh) | 一种保健亚麻粉及其生产方法 | |
| CN102919383A (zh) | 一种含牡丹籽油的调和油及其制备方法 | |
| CN102894107A (zh) | 一种营养核桃油及其生产工艺 | |
| CN103385493A (zh) | 以南极磷虾油为主料的健康食品 | |
| CN104082751A (zh) | 一种含有虾青素的深海鱼油软胶囊 | |
| CN105076495A (zh) | 一种保健调和油及其制备方法 | |
| CN104171025A (zh) | 一种适合妇女儿童的富硒食用油 | |
| CN101843336A (zh) | 亚麻油脂肪乳口服溶液、饮料及制造方法 | |
| CN103082034A (zh) | 一种保健调和油 | |
| CN103989179A (zh) | 含有银杏叶提取物的深海鱼油软胶囊 | |
| CN102232430A (zh) | 保健油 | |
| CN101816423A (zh) | 紫苏籽油脂肪乳口服溶液、饮料及制造方法 | |
| CN1108891A (zh) | 含多不饱和脂肪酸的强化牛奶 | |
| CN108651635A (zh) | 具有健脑补脑功效的营养均衡的健康食用油 | |
| CN103989181A (zh) | 核桃油鱼油软胶囊 | |
| CN104000208A (zh) | 一种含有角鲨烯的深海鱼油软胶囊 | |
| CN103989180B (zh) | 含有丹参提取物的深海鱼油软胶囊 | |
| CN103989176B (zh) | 含有葛根提取物的深海鱼油软胶囊 | |
| CN104187676A (zh) | 含有葛根提取物的海狗油软胶囊 | |
| CN104187727A (zh) | 含有丹参提取物的海狗油软胶囊 | |
| CN103651968B (zh) | 一种大鲵紫苏调和油及其制备方法 | |
| CN104187674A (zh) | 含有银杏叶提取物的海狗油软胶囊 | |
| CN104187675A (zh) | 含有银杏叶油的海狗油软胶囊 | |
| CN104187728A (zh) | 含有核桃仁提取物的海狗油软胶囊 | |
| CN104187726A (zh) | 含有罗布麻提取物的海狗油软胶囊 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141210 |